125 related articles for article (PubMed ID: 21839543)
1. Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees.
Kowada A
Am J Infect Control; 2011 Dec; 39(10):e67-72. PubMed ID: 21839543
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
Kowada A
Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation.
Kowada A
Eur J Radiol; 2013 Aug; 82(8):1353-8. PubMed ID: 23489981
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations.
Kowada A; Deshpande GA; Takahashi O; Shimbo T; Fukui T
Mol Diagn Ther; 2010 Aug; 14(4):229-36. PubMed ID: 20799765
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
Oxlade O; Schwartzman K; Menzies D
Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening.
Kowada A
Mol Diagn Ther; 2012 Jun; 16(3):181-90. PubMed ID: 22594558
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.
Kowada A
Epidemiol Infect; 2016 Nov; 144(15):3215-3225. PubMed ID: 27412626
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries.
Kowada A
Travel Med Infect Dis; 2016; 14(5):489-498. PubMed ID: 27238907
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries.
Kowada A
J Infect; 2014 Jan; 68(1):32-42. PubMed ID: 23973660
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy.
Kowada A
Mol Diagn Ther; 2010 Dec; 14(6):367-73. PubMed ID: 21275454
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan.
Kowada A; Takahashi O; Shimbo T; Ohde S; Tokuda Y; Fukui T
Mol Diagn Ther; 2008; 12(4):235-51. PubMed ID: 18652520
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
Kowada A
Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
Kowada A
J Infect; 2019 Jan; 78(1):58-65. PubMed ID: 30009853
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
